)
Meiji (2269) investor relations material
Meiji Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 FY2026 consolidated operating profit rose to JPY 22.7 billion, up 27.7% year-over-year, with significant profit increases in both Food and Pharmaceutical segments.
Net sales rose 5.8% year-over-year to JPY 289.4 billion, with profit attributable to owners of parent up 51.3%.
Comprehensive income nearly doubled year-over-year, reflecting strong operational performance.
Structural reforms advanced in Japan and overseas, including business transfers and plant closures.
Financial highlights
Operating profit margin improved to 7.8% from 6.5% year-over-year.
Ordinary profit was JPY 24.8 billion, up 37.8% year-over-year.
Profit attributable to owners of parent increased 51.3% to JPY 15.3 billion.
EPS rose to JPY 56.33 from JPY 37.27 year-over-year.
Gross profit margin improved, with gross profit up 11.1% year-over-year.
Outlook and guidance
Full-year net sales forecast at JPY 1,212.0 billion (+3.3% year-over-year), with operating profit projected at JPY 100.0 billion (+9.9%).
Profit attributable to owners of parent expected to reach JPY 62.5 billion (+78.2%), with EPS forecast at JPY 230.61.
No revisions to H1 or full-year guidance.
Dividend payout ratio for FY2026 forecast at 81.1%.
- Operating profit rose but net profit fell sharply on China impairment; rebound expected.2269
Q4 2026 - Impairment in China drives restructuring, with renewed focus on growth, ROE, and innovation.2269
Investor presentation - Operating profit rose on Food segment strength, but net profit fell on higher costs and impairment.2269
Q3 2026 - Operating profit beat plan, but sales forecast lowered amid cost pressures and ongoing reforms.2269
Q2 2026 - Profits declined in Q1, but full-year outlook and dividend plans remain strong.2269
Q1 2026 - Pharmaceuticals drove profit growth as food margins fell; full-year outlook and share cancellation steady.2269
Q2 2025 - Sales and profit rose, led by pharmaceuticals, despite food margin pressures.2269
Q1 2025 - Sales and profit growth continue, with higher dividends and strategic investments ahead.2269
Q4 2025 - Sales growth offset by pharma and vaccine losses; outlook remains cautious.2269
Q3 2025
Next Meiji earnings date
Next Meiji earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage